T45.626

Clinical Causes: Lack of proper medical guidance or misunderstanding of dosage instructions Patient non-compliance or intentional skipping doses Concerns about side effects leading to reduced intake Labeling or prescription errors Limited access to healthcare services or medications Pharmacist or healthcare provider oversight

Key Symptoms: Uncontrolled bleeding or bleeding that persists longer than usual Swelling or pain at injury sites Bruising easily or extensively Increased bleeding during or after surgical procedures Development of hematomas (localized collections of blood outside blood vessels) Signs of anemia in severe cases, such as fatigue or pallor

Diagnosis Path: Diagnosis primarily involves clinical assessment and review of the patient's medication history. Healthcare professionals may perform laboratory tests, such as clotting factor levels, activated partial thromboplastin time (aPTT), or specific assays to evaluate the effectiveness of hemostatic drugs. Monitoring medication adherence and reviewing prescribing practices are also vital components of diagnosis.

Treatment Protocols: Management focuses on correcting the underdosing issue to restore effective hemostasis. This may include: - Adjusting the medication dosage under medical supervision - Educating the patient about proper medication use and adherence - Ensuring regular follow-up appointments to monitor blood clotting parameters - Addressing any underlying barriers to proper medication intake, such as side effects or access issues - In some cases, administration of additional hemostatic agents might be necessary to control bleeding until proper dosing is established It is essential to work with healthcare providers to determine the appropriate approach for each individual, ensuring safety and effectiveness of treatment.